RCMI Coordinating Center (RCMI CC) Header Logo

Connection

Jason A. Rosenzweig to Enterocolitis, Pseudomembranous

Back to Details
This is a "connection" page, showing publications Jason A. Rosenzweig has written about Enterocolitis, Pseudomembranous.
Jason A. Rosenzweig
Connection Strength
0.140
Enterocolitis, Pseudomembranous
  1. Andersson JA, Fitts EC, Kirtley ML, Ponnusamy D, Peniche AG, Dann SM, Motin VL, Chauhan S, Rosenzweig JA, Sha J, Chopra AK. New Role for FDA-Approved Drugs in Combating Antibiotic-Resistant Bacteria. Antimicrob Agents Chemother. 2016 06; 60(6):3717-29.
    View in: PubMed
    Score: 0.140
Connection Strength

The connection strength for concepts is the sum of the scores for each matching publication.

Publication scores are based on many factors, including how long ago they were written and whether the person is a first or senior author.
RCMI CC is supported by the National Institute on Minority Health and Health Disparities, National Institutes of Health (NIH), through Grant Number U24MD015970. The contents of this site are solely the responsibility of the authors and do not necessarily represent the official views of the NIH

For technical support please contact support